Malaria

Genetic Engineering Targets Mosquitoes with Scorpion Venom

Published in TB and Outbreaks Week, July 25th, 2000

Peptides in scorpion venom are suddenly making medical news.

Researchers in Mexico say malaria could be stopped in its tracks by genetically engineered mosquitoes that produce a scorpion toxin in their gut, according to an article in the July 8 issue of New Scientist.

Meanwhile, researchers in California are synthesizing similar compounds as immunosuppressants for treating transplant recipients and patients with autoimmune disorders (H. Wulff et al., Proceedings of the National Academy of Sciences, July 3, 2000; and see the July 26 issue of NewsRx.com's Immunotherapy Weekly).

For years, scientists have dreamed...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2000-07-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry